⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1497168 | 0.74 | — | — | |
| SCHEMBL31705302 | 0.74 | — | — | |
| Hydrochloric Acid SCHEMBL729859 | 0.72 | — | — | |
| SCHEMBL17840234 | 0.69 | — | — | |
| SCHEMBL8988873 | 0.67 | — | — | |
| SCHEMBL1668811 | 0.67 | — | — | |
| SCHEMBL15927307 | 0.67 | — | — | |
| SCHEMBL19234198 | 0.67 | — | — | |
| SCHEMBL1669127 | 0.67 | — | — | |
| SCHEMBL12949962 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2099453-A2 | COMBINATION THERAPY OF SUBSTITUTED OXAZOLIDINONES | Bayer Schering Pharma Aktiengesellschaft (DE) | 2009-09-16 | — | — | EP | disclosed |
| WO-2008052671-A2 | COMBINATION THERAPY OF SUBSTITUTED OXAZOLIDINONES | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-05-08 | — | — | WO | disclosed |